Avicanna To Bring Its CBD-Based Drugs To Latin America Via Chilean Pharma Partner

-focused biopharmaceutical company Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) revealed Friday that it has partnered with Chile's Knop Laboratorios S.A. to supply a range of cannabinoid-based active pharmaceutical ingredients for the manufacturing and commercialization of proprietary cannabinoid-based pharmaceutical products in Latin America.

The deal between Avicanna's majority-owned subsidiary Santa Marta Golden and the established Chilean pharmaceutical company further solidifies Avicanna's and Knop's collaboration.

Since 2018, Avicanna and Knop have developed a collaborative enterprise that has led to commercial …

Full story available on Benzinga.com

More Avicanna To Bring Its CBD-Based Drugs To Latin America Via Chilean Pharma Partner